Member Info for ConsDoms

and do you realise India, worse than anything else, your constant moaning will probably encourage old tuna face to make an appearance

same old from you India.
your get rich quick punt has not come off (yet) so you come on here to moan (your prerogative)
but you constantly contradict yourself...
''I am very confident things have to change...''
''What a joke ... Our money has been dead in this stock for so long...''
''I just wish i had a little more to purchase now before the bounce again''
If you are not sure where these BUYERS are going to come from why did you invest in the first place?
Why dont you share the one main reason why you invested in HEMO or did you get mugged off?
Would you recommend others invest in HEMO now?

great piece on leukaemia treatment on this mornings todays programme.
I really dont think we need to concern ourselves about profile raising IF we get approval to go clinical.
treatment of blood cancer (and CAR T) is very prominent imho.
best wishes

ffs

wow MrI.
I dont agree about lack of updates ...but that is getting close to a sensible post...
happy hols

some posts removed but unfortunately most of your illegible gibberish remains tuant

nope sorry.
none the wiser tuant.
your writing is just complete gibberish

i dont think anyone can understand you tuant

if only we could make out what the fk you are saying tuant. then we could perhaps have a sensible exchange.
I think its fair to say nobody can understand you - you are just talking to yourself.
Your time may be better spent taking a few English grammar lessons...

Mr I
I really think your holding will look very strong relatively soon.
It may not be until late spring / summer but the indications are good.
There is every reason to be positive.
Nobody knows for definite but IND approval / going clinical should bring significant new interest in HEMO.
GLA

do you not know what is happening with CBR and CDX? - no i dont and it would be pointless speculating

so you dont believe any rerate is expected with IND in Feb? - thats not what I said - nobody knows the exact time - progress looks very good - the July RNS refers 1H23

India
ffs stop using 'we'. - speak for yourself only. Ive not said it will rerate for 12months.
I expect rerate over the 1H23 in line with July RNS.
You made up your own deadlines and now cant live with the fact you got it wrong.
Maybe the sellers are EXACTLY LIKE YOU i.e. they had personal reasons...

fair play to you woodcot.
I wish you well.
I dont believe we have heard you moan once

India
you are speaking for everyone again - it is not right. I have every confidence.
I cant stand your constant moaning, its truly awful. But there are occasions I feel for you - seems like you went in with money you could not afford to lose.
But to hear you actually sold having whined like fk about those that do....unbelievable

'rather than keeping quietly and letting people like Tuan manipulate people's sentiment'
ha! you are a card india
anybody influenced by tuna wants carting off.

tuant

if you do anything please stick an 'i' in your dong...

''I can guarantee the only people who have happiness with vlad is his family ... no one on here shouod be happy unless they enjoy sitting on a stock for 3 years in the red !!!''

Please stop talking for all investors. It is incorrect.
I am down on paper only and have been very happy to pick up more and average down.
I am very happy with my holding.

How is 18th November old news? You whine like fk over stuff that is months / years old

Thanks for little reminder HK - nice little afternoon tonic

''Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new
therapies and treatments for deadly blood diseases, is pleased to announce the successful
completion of its second and final Process Development (“PD”) run of the end-to-end process for
the manufacture of HEMO-CAR-T cells. The process was carried out in the Company’s current Good
Manufacturing Practice (“cGMP”) compliant clean rooms.
This is another step for the Company in its preparation of the Investigational New Drug (“IND”)
application to the US Food and Drug Administration (“FDA”) required to authorise commencement
of Phase I clinical trials of HEMO-CAR-T. The Company’s amazing team of scientists is now moving
toward engineering runs (Process Qualification) of HEMO-CAR-T cell production''

'This has been a complete shambles of a stock and no one can deny that' - Im denying it MrI. Please just speak for yourself only.
the first half of 2023 will determine if this has 'been a complete shambles' as you put it.
Im still lost why you continue to make up your own deadlines and then become distressed when your deadlines are not met

not just at first tuant

your spouting of utter utter bull **** knows no bounds